Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients
Clinical trial NCT02002702 · COMPLETED
Trial details
- NCT number
- NCT02002702
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-08-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.